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April 12, 2019          
Office of the CALS Dean 
110 Morrill Hall 
Burlington, VT 05405 
 
To the DUR Committee,  
I hope this letter finds you well. Today, I am writing to you regarding my DUR project 
that I have completed under the supervision of Dr. John Barlow, DVM, PhD in the 2018 – 2019 
Academic Year. Dr. Barlow has served as my research mentor since the 2017 Spring semester. 
Since joining his lab, I assisted with the Honors College Thesis projects of Amber Davis ’18 and 
Heather Schuettner ’18, who taught me basic laboratory and research skills and inspired me to 
take on my own DUR Thesis evaluating the antimicrobial properties of cinnamon bark oil.  
Dr. Barlow and I met several times during the Spring ’18 semester to develop the 
experimental design and scope of my project. I applied and was awarded the Public Impact 
Research Award from the FOUR Office which made it possible for me to begin my project over 
the summer. The four assay procedures were extrapolated from past studies, and Dr. Barlow and 
I would meet before I started each assay to assess the materials we had and refine the procedure 
accordingly. Juggling lab work with barn chores at the CREAM Farm this summer taught me a 
great deal about time resiliency, diligence, and the importance of mistakes. Since there were 
several other students working on their own projects and no graduate students, undergraduate 
students, or laboratory technicians to help me, I was responsible for completing each assay and 
recording the results throughout the summer and school year. I would update Dr. Barlow as I 
progressed and consulted him if significant errors were consistently made in my project. 
Otherwise, I was held accountable for the work I completed, scheduling my hours, and the 
mistakes I made, which required both patience and significant trouble-shooting skills. Each assay 
presented its own challenges, and the two most significant were regarding contamination and 
how labor-intensive some assays were.  
One assay took several months to complete due to contamination issues, which taught me 
the importance of using positive and negative controls in my experiment to help pinpoint where 
the sources of error had originated from. As these trials were also completed during the academic 
year, the other main concern was time management. Many of these procedures took several 
hours to complete, often requiring multiple consecutive days to produce and record results. As a 
solution, I dedicated my weekends to experimentation and the school week to preparing supplies 
(pipette tips, agar plates, broths, etc.) and reading results. This was the most difficult when 
assays required hundreds of Mueller-Hinton plates had to be made in-house on a weekly basis. 
However, over time, I became more efficient with carrying out these assays. Interestingly, I was 
also enrolled in MMG 101 at the time, and the lab portion of the course helped refine many of 
the basic Microbiology lab skills that helped me understand how to interpret my results and 
where potential sources of contamination were stemming from.   
Compiling my work into a poster presentation, oral presentation, and thesis instilled a 
great sense and accomplishment in my work. Without this experience granted to me by the DUR 
Committee, Dr. Barlow, and FOUR Office, I would have never discovered my profound 
appreciation and interest research. Being a part of a study that could potentially contribute to a 
greater cause in the dairy community was an incredibly humbling and empowering way to end 
my Undergraduate career.  
Sincerely,  
 Samantha Keum 
Interpretive Summary 1 
 2 
In vitro methods of antimicrobial susceptibility produce different estimates of cinnamon bark oil 3 
minimum inhibitory concentration for Staphylococcus aureus isolates from organic dairy farms 4 
By Samantha J. Keum 5 
  6 
 Bovine mastitis is an intramammary infection caused by bacteria such as Staphylococcus 7 
aureus associated with significant economic losses for dairies. Antimicrobial agent alternatives 8 
for mastitis are needed for organic dairy farmers. Essential oils (EO) possess significant 9 
antimicrobial properties, but current antimicrobial susceptibility tests have produced varying 10 
estimates of EO minimum inhibitory concentrations (MIC). This study analyzed the differences 11 
in cinnamon bark oil’s (CBO) MIC for the same S. aureus isolates among assays. We observed 12 
that every isolate’s CBO MIC varied by assay. Creating antimicrobial susceptibility assays 13 
conducive to EO properties is necessary before EO can serve as antimicrobial agent alternatives.  14 
 15 
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ABSTRACT 36 
 37 
 Staphylococcus aureus causes mastitis in dairy cattle, resulting in significant drops in 38 
production and profits for dairy farmers. Mastitis treatment and prevention is the leading cause 39 
of antimicrobial agent use on conventional dairies. As antimicrobial agent resistance to current 40 
penicillin-based treatments is on the rise, it is pertinent that alternative mastitis treatments are 41 
researched. Several studies have suggested that plant-derived essential oils (EO) could serve as 42 
alternative treatments and supplements for dairy farmers. However, significant deviations in 43 
results have been noted in studies determining the susceptibility of S. aureus to EO in 44 
antimicrobial susceptibility assays. This study compared the differences in susceptibility to 45 
Cinnamon Bark oil (CBO) of 48 different S. aureus isolates collected from 26 organic dairy 46 
farms in Vermont using 4 common antimicrobial assays: AD, BM, DD, and VP. In vitro, the 47 
same 48 S. aureus isolates produced significantly different CBO MIC values across each 48 
treatment but not amongst each other. On average, VP had the highest CBO MIC values, 49 
followed by DD, and AD. BM had the lowest CBO MIC values on average. This suggests that 50 
these differences of CBO MIC values for each isolate are attributed to the assay type. However, 51 
isolates in the VP assay had notably higher CBO MIC values. With consistent susceptibility to 52 
CBO recorded for all isolates among all assays, plant-derived EO have the potential to supply an 53 
equitably effective, sustainable alternative to conventional antimicrobials used against S. aureus.   54 
 55 
 56 
 57 
 58 
 59 
 60 
 61 
 62 
 63 
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 66 
INTRODUCTION 67 
 68 
 The antimicrobial properties of essential oils (EO) have been utilized since the 13th century 69 
because of their preservative abilities, aromas, flavors, and their pharmacological properties (Kurt 70 
Bauer et al., 2001). EO are produced from plants as lipid-soluble secondary metabolites that both 71 
protect the plant and attract seed dispersers. Steam distillation or mechanical expression are the 2 72 
main processes of producing plant-derived EO. Plant-derived EO are comprised of a variety of 73 
complex volatile compounds and a generally soluble in alcohol, ether, and vegetable or mineral 74 
oils. These hydrophobic components are classified as either terpenes or aromatichydrocarbons 75 
which are responsible for each EO’s unique properties (Bakkali et al., 2008).  76 
 77 
 Cinnamon Bark oil, derived from the evergreen tree Cinnamonum zeylanicum, (CBO) was 78 
used as the EO treatment because previously published work and projects in the Barlow Lab have 79 
demonstrated its antimicrobial properties against Staphylococcus aureus. S. aureus is a zoonotic 80 
pathogen responsible for food poisoning, toxic shock syndrome, and post-operative wound 81 
infections for humans (Becerril, Gómez-Lus, Goñi, López, & Nerín, 2007; Zhang, Pingping Jiang, 82 
SiewYoung Quek, Xiaoyu Liu, & Yifei Wang, 2016). Across all plant-based cinnamon EO, 2 main 83 
aromatic compounds, determined by gas chromatography-mass spectrometry, are responsible for 84 
its antimicrobial properties: eugenol and trans-cinnamaldehyde (López et al., 2007; Bakkali et al., 85 
2008; Friedman, 2017). Trans-cinnamaldehyde and eugenol have been reported to significantly 86 
inhibit the growth of both Gram positive and negative bacteria, as well as yeasts (Ali et al., 2005; 87 
Suppakul, 2016; Friedman, 2017). The potential of supplementing or replacing artificial 88 
compounds in both the food industry and medical fields with EO has powered several studies to 89 
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evaluate and analyze their unique properties (Goñi et al., 2009; Mullen et al., 2014; Zhang et al., 90 
2016).  91 
 92 
 Several strains of staphylococci responsible for mastitis, especially S. aureus, have shown 93 
significant resistance towards penicillin-based antimicrobial agents, (Pyörälä, 2009), and the 94 
World Health Organization has warned that these pathogenic bacteria will mutate at rates faster 95 
than antimicrobial agents can be developed, stressing the need for more sustainable alternatives 96 
(World Health Organization, 2017).  CinnatubeTM (New Agritech Inc., Locke, NY) and Phyto-97 
MastTM (CowMaster, Graham, NC) are antimicrobial agent alternatives marketed to the organic 98 
dairy industry for mastitis control. These products are available as formulations that contain 99 
several plant-derived EO, including cinnamon oil, as ingredients and are packaged as 100 
intramammary infusion devises. The formulations are not FDA approved for treatment of mastitis, 101 
although the manufacturers promote the ingredients are “generally recognized as safe” by the 102 
USDA for human consumption. The most credible study involving herbal alternatives for mastitis 103 
treatment compared CinnatubeTM and Phyto-MastTM to conventional dry cow therapy, but no 104 
differences in milk yield, somatic cell score between lactations, or mastitis cure rates were proven 105 
between the treated group and the untreated group, despite the known antimicrobial properties of 106 
each product’s EO (Mullen et al., 2014). Organic milk product sales have doubled between 2006 107 
and 2011, and organic dairy farmers are struggling to meet this demand without adequate 108 
alternative mastitis treatments available (Zwald et al., 2004).  More research examining the 109 
composition, efficacy, and mode of application of CinnatubeTM and Phyto-MastTM is integral to 110 
proving the efficacy of these products.  111 
 112 
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 Several studies have been conducted, analyzing the antimicrobial properties of EO, 113 
including those found in CinnatubeTM and Phyto-MastTM. Similarly to conventional drugs, there 114 
may be clinical relevance to determine the in vitro minimum inhibitory concentration (MIC) values 115 
for certain microbes using antimicrobial assays. Significant differences have been discovered 116 
between several common antimicrobial susceptibility methods used to determine EO MIC values: 117 
agar disc diffusion (DD), agar dilution (AD), broth micro titer plate dilution (BM), and vapor phase 118 
diffusion (VP) (Burt, 2004; López et al., 2005; Goñi et al., 2009; Balouiri et al., 2016). It is 119 
important that methodologies are evaluated to confirm the accuracy of the results generated in past 120 
publications determining MIC values for EO. It is also unknown if bacteria can develop resistance 121 
to EO and data from susceptibility assays using uniform methods can be used to compare the 122 
susceptibility of isolates over time or from different geographic regions or animal production 123 
systems (Hili et al., 1997; Hammer et al., 1999; Vieira-Brock et al., 2017).  124 
 125 
 A comparative analysis using 4 methods, evaluating CBO’s inhibition of S. aureus, has yet 126 
to be conducted. Determining the most effective methods would provide the foundation needed to 127 
confidently pursue future studies examining the potential of incorporating EO in alternative 128 
antimicrobial medications for animals and humans alike. The objective of this research is to 129 
conduct a comparative study, analyzing S. aureus’ susceptibility to CBO with DD, AD, BM, and 130 
VP methodologies, using penicillin as the control. It is hypothesized that that the MIC of CBO for 131 
S. aureus observed for the BM and AD methods will be lower than the MIC values for either DD 132 
or VP methodologies. We speculate that the lower MIC values are related to the direct contact 133 
made between the CBO suspended in agar or broth medium and the bacteria, in contrast to the 134 
CBO vapors escaping the VP plates and paper discs in the DD method.  135 
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MATERIALS AND METHODS 136 
 137 
Bacterial Isolates and Strains 138 
Forty-eight S. aureus isolates were used. These isolates were from milk samples collected 139 
on 41 different organic dairy farms in Vermont, representing common strains causing mastitis in 140 
dairy cattle. The strain types and antimicrobial susceptibility profiles to conventional antimicrobial 141 
agents (e.g. penicillin (PEN), tetracycline, and erythromycin) have been characterized, and 3 142 
American Type Culture Collection (ATCC) control S. aureus strains (ATCC 25923, ATCC 29213, 143 
and ATCC 33591), with different antimicrobial susceptibilities, were evaluated (Mugabi et al., 144 
unpublished). The isolates were revived from frozen stock by streaking 10 uL of the stock solution 145 
for isolation on the primary blood agar plates that were incubated for 48 hours at 37o C. Ten μL 146 
aliquots, or beads if present, were also transferred into tubes containing 11 mL of Tryptic Soy 147 
Broth as an alternative method to recover isolates. If positive, pure growth was present, a single 148 
colony from the primary plate was transferred onto a secondary blood agar plate which was 149 
incubated for 24 hours at 37o C. If positive, pure growth was confirmed for the secondary plate, 150 
the secondary plates were used as stock plates for the assays for up to 1-2 months. Isolate revival 151 
was repeated 3 times throughout this study.  152 
 153 
0.5 McFarland standard solutions were required for each assay’s procedure. These 154 
solutions were prepared from the transfer of a single, isolated S. aureus colony into 3-5 mL of 155 
sterile, buffered water and vortexed, and the solution was diluted to obtain a 0.5 McFarland 156 
turbidity when visually compared to a turbidity standard. For the purpose of this study, it was 157 
assumed a 0.5 McFarland standard contains approximately 1-2 x108 CFU/mL, as suggested by 158 
CLSI Guidelines (CLSI, 2013).  159 
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Essential Oils 160 
Food grade (Food Chenical Codex) CBO (55-78% cinnamic aldehyde; Sigma-Aldrich, 161 
Inc.) from a single lot was used thought out this study. Using the BM assay, the MIC of CBO for 162 
selected S. aureus isolates was determined to be 1.0 mg/mL (Zhang et al., 2016; Hart & Barlow, 163 
unpublished). However, recent work using the AD method, in the Barlow lab, suggests that the 164 
MIC is 0.25 mg/ml for a panel of S. aureus isolates obtained from milk of organic dairy cattle 165 
(Amber Davis, 2018 Honors Thesis, unpublished). The observed differences may relate to the 166 
selection of isolates, but also the in vitro methods employed. This experiment was designed to 167 
follow up on these preliminary observations that the predicted MIC may differ among assays. CBO 168 
concentration percentages were calculated by calculating the μLCBO or μgCBO/mLSOLUTION  169 
 170 
Antimicrobial activity testing in vitro 171 
All bacterial inhibition assays were conducted in triplicate on cation adjusted Mueller-172 
Hinton (MH) agar (BBLTM Mueller Hinton II Agar, Becton Dickinson and Company, Sparks MD) 173 
or in MH broth (BBLTM Mueller Hinton II Broth, Becton Dickinson and Company, Sparks MD), 174 
in concordance with Clinical Laboratory Standards Institute (CLSI) methods (CLSI, 2013), and 175 
the results reported as the mean and variance for each assay for each isolate. 0.5 McFarland 176 
solutions were used as turbidity standards in each assay. The number of estimated cells used in 177 
each assay was calculated from this estimated ratio consistent with the CLSI Guidelines, and the 178 
frequency of quality control testing adhered to the CLSI recommendations  (CLSI, 2013). 179 
 180 
 181 
 182 
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Agar Dilution Assay 183 
Mueller-Hinton (MH) plates containing 2-fold serial dilution concentrations of CBO (1 184 
μgCBO/mL, 0.5 μgCBO/mL, 0.25 μgCBO/mL, 0.125 μgCBO/mL, and 0.0625 μgCBO/mL) were 185 
prepared. A dehydrated base of MH agar was combined with ddH2O, autoclaved according to the 186 
manufacturer’s directions, and cooled in warm water baths until 45-500 C was reached. The 187 
appropriate CBO solution was slowly combined into each MH solution in the biological safety 188 
cabinet. Tween-80 was used as an emulsifying agent for the CBO to ensure proper solubilization 189 
within the agar, present at 2 μg/mL in each CBO solution. Two control plate types were used: one 190 
without CBO or Tween-80 (“positive” no inhibitor control agar) and one with 2 μg/mL Tween-80 191 
(“excipient control agar”). Sterile microloops transferred 1 μL volumes, each containing 100,000 192 
CFU, of a vortexed 0.5 McFarland standard bacterial suspension of each isolate onto a pre-labeled 193 
spot on a MH plate of a known CBO concentration. Plates were incubated for 18-24 hours at 37°C. 194 
Absence of growth in positive control plates indicated the experiment and needed to be repeated. 195 
Plates were observed for colony growth and homogeneity. As seen in Figure 10, this method 196 
allowed us to evaluate the MIC of 6 isolates per plate and was repeated in duplicate as done in 197 
previous experiments in the Barlow Laboratory (Amber Davis, 2018 Honors Thesis, unpublished).  198 
 199 
Vapor Diffusion Assay 200 
The 48 S. aureus isolates were serially diluted with ddH2O and approximately 100 μL of a 201 
0.5 McFarland, was swabbed for confluency on a MH plate and left to dry. The CBO was serially 202 
diluted with ethyl ether into 6 different CBO concentrations: 80 μgCBO/mL CBO, 40 μgCBO/mL 203 
CBO, 20 μgCBO/mL CBO, 10 μgCBO/mL CBO, 5 μgCBO/mL CBO, and 2.5 μgCBO/mL CBO. 204 
Each 6 mm sterile blank filter paper discs was impregnated with 20 μL of a CBO solution in ethyl 205 
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ether. Each disc was placed in the center of the Petri dish lid using sterile tweezers in a fume hood. 206 
The plates were incubated for 18-24 hours at 37°C. As seen in Figure 8, plates were observed for 207 
presence or absence of a zones of inhibited growth above the paper discs, which were compared 208 
to positive control plates - sham discs containing only ethyl ether (López et al., 2005; Matusiak et 209 
al., 2018). For logistical reasons and successful replication of values, this assay was conducted in 210 
duplicate. 211 
 212 
Agar Disc Diffusion Assay 213 
 A 100 μL volume of a 0.5 McFarland standard of S. aureus isolatewas plated as a confluent 214 
lawn on MH agar plates using a sterile swab. After the solution had dried, a sterile filter 6 mm 215 
paper disc impregnated with 5 μL of one of the 6 CBO concentrations (2 μgCBO/mL,1 216 
μgCBO/mL, 0.5 μgCBO/mL,0.25 μgCBO/mL,0.125 μgCBO/mL, and 0.0625 μgCBO/mL) and 217 
placed directly onto the surface with sterile tweezers. Each CBO solution was created using CBO 218 
and ddH2O combined with Tween-80 at 0.2 μgCBO/mL as the emulsifying agent. Six different 219 
CBO containing discs will be placed on each test plate and 2 discs on each control plate. One disc 220 
of the control plate was impregnated with 10 μL of ddH2O and one with 10 μL of penicillin at a 221 
20 μg/mL concentration. All plates were incubated for 18-24 hours at 37°C. The diameter of the 222 
zone of inhibited growth surrounding the paper discs, as seen in Figure 10, was measured and 223 
recorded (Zhang et al., 2016, CLSI, 2013). Trials were repeated for isolates that failed to create 224 
zones of inhibition at the same CBO concentration. For logistical reasons and successful 225 
replication of values, this assay was conducted in duplicate. 226 
 227 
 228 
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Broth Microdilution Assay  229 
Eight MHB solutions were prepared at 6 different CBO concentrations: 2 μgCBO/mL, 1 230 
μgCBO/mL, 0.5 μgCBO/mL, 0.25 μgCBO/mL, 0.125 μgCBO/mL, and 0.0625 μgCBO/mL, and 231 
the remaining 2 MHB solutions were used as uninoculated controls: one with and one without 232 
Tween-80. As seen in Figure 9, a 96-well clear round bottom microdilution tray (1Costar Assay 233 
Plate 3788, Corning Inc, Corning NY) was filled, containing 0.05 mL of CBO broth per well. Each 234 
row represented a different CBO treatment. Tubes of 4 mL of MH broth (MHB), with 10 μL of an 235 
S. aureus isolate at a 0.5 McFarland standard were prepared. Using an eight channel pipet, 0.05 236 
mL of one S. aureus isolate was added to each well down each column of a plate. Each well 237 
therefore contained approximately 5x106 CFU. The plates were covered in Parafilm and incubated 238 
for 18-24 hours at 37°C. Presence of growth based on visual examinationwas recorded for each 239 
well. Controls will be tested without the incorporation of CBO in a row for the positive control 240 
and a without CBO or S. aureus in the negative control (CLSI, 2013). Additional 96-well 241 
microdilution trays, containing penicillin as the inhibitor instead of CBO, were used as a 242 
comparison for differences in MIC values between the 2 inhibitors and a confirmation for 243 
previously determined MIC values of specific isolates (Mugabi et al., unpublished). This assay 244 
was repeated in triplicate. After the results were recorded, 1 μL loops transferred aliquots from 245 
one of the control wells for each isolate steaking for isolation onto blood agar plates in order to 246 
control for potential bacterial contamination wells. These agar plates were incubated for 18-24 247 
hours at 37°C. Trials were redone if the streaks for isolation suggested contamination with a 248 
different bacterial species or if the S. aureus isolate failed to grow in the positive control well 249 
which did not contain an inhibitor. Isolates that failed to produce CBO MIC values that were 250 
consistent in triplicate, within a single log2 dilution of each other were repeated.  251 
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Minimum Inhibitory Concentration Determination 252 
A 2-fold dilution series of CBO solutions and penicillin solutions were used to determine 253 
the MIC of each isolate in the 4 antimicrobial assays used. According to CLSI guidelines, MIC 254 
results that vary within 1log 2 dilution from each other are deemed acceptable. It is also understood 255 
that the true MIC value falls between the MIC value for penicillin or CBO recorded and the 256 
concentration that is a 2-fold dilution higher in this experiment (CLSI, 2013). All results that fell 257 
outside of this MIC bracket in duplicate or triplicate were removed from data analysis and repeated 258 
in each of the assays. The arithmetic mean was calculated across the trials completed for the BM 259 
and AD trials that were performed in triplicate and duplicate, respectively. VP and DD assays’ 260 
MIC values were recorded as the lowest concentration that zones of inhibition were recorded for 261 
each isolate.  262 
 263 
Statistical Analysis 264 
GraphPad Prism statistical software (GraphPad Prism v7.01) was used to calculate means 265 
and standard deviation of each isolate’s CBO MIC replicates, conduct Tukey’s multiple 266 
comparisons test, and significant differences determined by ANOVA with an alpha value set at 267 
0.05. 268 
 269 
RESULTS 270 
For the DD assay, 160 observations were removed from analysis because results between 271 
the agar plates in duplicate were inconsistent or failed to produce a lawn of bacteria on the plate. 272 
In the BM assay, 8760 observations were removed for several reasons. The majority of 273 
observations for the penicillin control trials were found to be contaminated when the blood agar 274 
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plates that were streaked for isolation from the control wells of each 96-well plate. The remaining 275 
observations that were removed failed to produce consistent results in triplicate. Isolates that did 276 
not produce MIC results that were within 1 log2 dilution of each other in the same CBO or PEN 277 
concentration (row of the 96-well plate) were repeated in this assay. Only these outliers were 278 
removed and replaced with more consistent, replicable results.  For VP, 268 observations were not 279 
used in statistical analysis for 4 main reasons. Firstly, because isolates failed to create similar zones 280 
of inhibition within 1 log2 dilution of each other when treated with the same CBO concentration. 281 
Secondly, isolates failed to grow pure, full lawns of bacteria in the plates and had to be repeated. 282 
Thirdly, and rarely, the impregnated filter paper discs were displaced from the center of the plate’s 283 
lid while transferring plates into the incubator, if they were tilted too much to one side while being 284 
carried and failed to create a zone of inhibition. Lastly, 144 observation of the 268 that were not 285 
used for statistical analysis because no zones of inhibition were observed at CBO concentrations 286 
of 2 μg/mL, 1 μg/mL, 0.5 μg/mL, 0.25 μg/mL, 0.125 μg/mL.  287 
 288 
Agar Dilution  289 
All 728 observations were retained for data analysis. Isolates MIC values against CBO 290 
ranged between 0.0625 μg/mL and 1 μg/mL (Figure 3). The number of replicated observations per 291 
an isolate were 2.  292 
 293 
Broth Microdilution 294 
 All 1152 observations in this assay were retained for data analysis. The CBO MIC values 295 
recorded for each isolate ranged from 0.0625 μg/mL to 1 μg/mL. The differences in CBO MIC 296 
values for each isolate was statistically significant (p < 0.0001), and the CBO MIC values for each 297 
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isolate across six trials did not significantly differ from each other (p = 0.1097), confirming 298 
repeatability of results. CBO averages for each isolate compared to their respective PEN MIC are 299 
included in Figure 4. 300 
 301 
Agar Disc Diffusion 302 
 768 observations were retained for statistical analysis. The CBO MIC range fell between 303 
0.250 μg/mL and 2 μg/mL, the MIC50 = 1 μg/mL, and the CBO MIC90 = 2 μg/mL. As seen in 304 
Figure 10, the averaged zones of inhibition recorded for 0.2 μg/mL CBO ranged between 6 mm 305 
and 43 mm, 0 mm and 44 mm for 0.1 μg/mL, 0 mm and 23 mm for 0.5 μgCBO/mL, and between 306 
0 mm and 15 mm for 0.25 μg/mL. No zones of inhibition were observed for isolates exposed to 307 
0.125 μg/mL, 0.0625 μg/mL, or the control (ddH2O). Zones of inhibition when exposed to the 308 
penicillin concentration (20 μg/mL) ranged between 15 mm and 67 mm in size. The largest zones 309 
of inhibition to CBO were recorded for isolates when exposed to 2 μg/mL, with a mean of 19.36 310 
mm. Overall, the isolates exhibited the largest zones of inhibition on average when treated with 311 
penicillin, with a mean of 46.45 mm (Figure 10). For all isolates, significant differences in zones 312 
of inhibition were not observed between all treatments when compared to ddH2O. All values for 313 
ddH2O were recorded as 0 mm because zones of inhibition were not produced, and no statistical 314 
significance of differences in treatments of isolates were recognized for 0.25 μg/mL (p = 0.7009) 315 
because the greater majority of zones of inhibition for this CBO concentration were 0 mm, with 316 
the exception of a few outliers. All zones of inhibition for isolates exposed to 0.5 μg/mL, 1 μg/mL, 317 
and 2 μg/mL significantly differed from all other  318 
 treatments and each other (p < 0.05).  319 
 320 
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Vapor Phase Diffusion 321 
 For statistical analysis 576 observations were retained. As shown in Figure 5, the range of 322 
the averaged zones of inhibition recorded for 10 μg/mL ranged between 0 mm and 11.5 mm, 0 mm 323 
and 40.5 mm for 20 μg/mL, 16.5 mm and 46.5 mm for 40 μg/mL, and 22 mm and 57.5 mm for 80 324 
μg/mL. The control, 2.5 μg/mL, and 5 μg/mL did not produce any zones of inhibition for the 48 325 
isolates tested in duplicate. Using a Tukey test of multiple comparisons and an ANOVA test, there 326 
were no statistically significant differences noted between the zones of inhibition recorded for 327 
isolates treated with the control compared to 10 μg/mL results (p = 0.7888). This is most likely 328 
due to only 2 isolates having zones of inhibition produced at this CBO concentration. Zones of 329 
inhibition for each isolate in all other CBO treatments compared to each other are confirmed to be 330 
statistically different (p < 0.0001). 331 
   332 
MIC Comparison Among Assays 333 
The penicillin MIC values for the 48 isolates used in this experiment were referenced from 334 
previous work in the Barlow Laboratory (Davis, Honors Thesis 2018, unpublished). As referenced 335 
in Figure 2, and speculated in our hypothesis, the averaged MIC values calculated for all isolates 336 
across the 4 assays and using PEN as an inhibitor, VP had the highest CBO MIC values recorded 337 
at 28.54 μg/mL MIC followed by DD with a 1.188 μg/mL MIC, 0.5562 μg/mL MIC for BM, and 338 
0.3576 μg/mL MIC for AD (Table 2). The average PEN MIC across the 48 isolates was at 0.4049 339 
μg/mL. The isolates in the VP assay had notably higher CBO MIC values compared to the other 340 
assays (p < 0.0001). 341 
 342 
 343 
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 344 
DISCUSSION 345 
 Results observed in this study were consistent with other research determining the CBO 346 
MIC values against S. aureus, as all 48 isolates exhibited consistent susceptibility to the CBO 347 
among the 4 assays. The antimicrobial properties associated with CBO are primarily attributed to 348 
its 2 major compounds (Figure 1): eugenol and trans-cinnamaldehyde, the 2 most active 349 
components against Gram positive and negative bacteria  (Sanla‐Ead et al., 2012; Li et al., 2013; 350 
Matusiak et al., 2018). EO, such as CBO, with higher amounts of phenolic compounds, such as 351 
eugenol, are known to have the most prominent antimicrobial properties (Burt, 2004; Cardoso-352 
Ugarte et al., 2016). Eugenol has expressed the ability to protect trans-cinnamaldehyde, a non-353 
phenolic component, from heat damage at temperatures as high as 200 o C (Friedman, 2017). The 354 
exact chemical composition of EO collected is determined using gas-chromatography-mass 355 
spectrometry (GC-MS), and percentages of each component present are determined by a variety 356 
of factors such as the part of plant the EO was harvested from, the time of harvesting, harvesting 357 
technique, and the plant species. In this study, GC-MS was not conducted on the CBO 358 
purchased, but it was assumed based on the exhaustive number of studies completed on CBO’s 359 
chemical composition that both trans-cinnamaldehyde and eugenol were present in high enough 360 
percentages to act as the main antimicrobial (Janssen et al., 1987; Burt, 2004). Future studies 361 
should incorporate the use of GC-MS to confirm that both eugenol and trans-cinnamaldehyde 362 
are the 2 main ingredients, especially if the same bottle of CBO is used over extensive periods of 363 
time. 364 
 365 
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S. aureus is a Gram positive bacteria, containing a single, thick peptidoglycan layer structure 366 
as opposed to Gram negative bacteria such as Escherichia coli which contains a notably thick 367 
layer of lipopolysaccharide that surrounds its thinner peptidoglycan layer. It is believed that the 368 
absence of a lipopolysaccharide layer in Gram positive bacteria makes it more susceptible to 369 
certain EO than Gram negative bacteria (Becerril et al., 2007; Burt, 2004). Currently, one of the 370 
most notable, speculated mechanisms of action for EO against bacteria is related to penetration 371 
of the bacteria’s cellular membranes. The retention of the cellular membranes in bacteria is vital 372 
for cell growth and metabolism, and even the slightest changes in membrane permeability and or 373 
integrity could result in cell death ( Zhang et al., 2016; Friedman, 2017). EO are hydrophobic in 374 
nature, permitting penetration of their chemical components into bacterial cell membranes, 375 
inducing morphological and permeability-based changes. Scanning electron microscopy, 376 
electrically conductive meters, and UV absorption have been utilized to track the effects of EO 377 
on microbes (Becerril et al., 2007; Lv et al., 2011; Zhang et al., 2016).  378 
 379 
Due to the overwhelmingly complex chemical compositions of EO, it has yet to be 380 
determined what exactly causes certain microbes to be susceptible to certain EO over others and 381 
whether specific methods of reaction are associated with specific EO groups (citrus, spices, 382 
floral, etc.). For example, oregano EO significantly inhibited growth against Gram negative and 383 
positive bacteria as well as yeast, but basil and bergamot EO were only effective against Gram 384 
positive bacteria (Bakkali et al., 2008; Lv et al., 2011). A study by Oussalah, Caillet, Saucier, & 385 
Lacroix found the inhibitory effects of 60 different essential oils against Pseudomonas putida 386 
using AD methods: Gram positive bacteria, such as S. aureus,  are more sensitive to the presence 387 
of EO from spices, including CBO, and herbs than Gram negative bacteria (Oussalah et al., 388 
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2006). Moreover, dozens of properties and mechanisms of action have been speculated in studies 389 
analyzing the antimicrobial effects of EO: cytoplasmic mutagenicity, phototoxicity, nuclear 390 
mutagenicity, carcinogenicity, and either synergism or antagonism with other EO or cellular 391 
metabolites (Bakkali et al., 2008). What we found interesting is that despite the multifaceted 392 
nature of EO, known for their aromatic, preservative, and antimicrobial properties, there has yet 393 
to be an antimicrobial susceptibility test specifically created to accurately evaluate the MIC of 394 
EO against microbes. Antimicrobial susceptibility tests originally made to evaluate conventional 395 
antimicrobial agents, which possess significantly different chemical properties, have only been 396 
slightly altered for EO use (Burt, 2004; Goñi et al., 2009).  397 
 398 
Our study confirmed that all 48 isolates’ CBO MIC values varied by assay type. These 399 
differences were especially noticed when comparing direct (BM, AD, DD) and non-direct 400 
contact methods (VP) which is in agreement with other studies analyzing the differences of 401 
bacterial growth inhibition when directly exposed to the EO versus EO vapors, including those 402 
of CBO and S. aureus (Burt, 2004; Becerril et al., 2007; Vieira-Brock et al., 2017). When the 403 
average CBO MIC values of each isolate among assays were compared to each other, it was 404 
found that there were significant differences (p < 0.0001) calculated, unlike conventional 405 
antimicrobial agents which rarely differ within a single log2 dilution of each other among 406 
different assays. As noted in other studies, more extensive chemical analysis needs to be 407 
conducted on EO to explain the similarities and differences between the antimicrobial properties 408 
of conventional antimicrobial agents and natural antimicrobials such as CBO (Burt, 2004; 409 
Edwards-Jones et al., 2004).  In the same vein, we also found it interesting that 7 isolates 410 
determined to be penicillin-resistant expressed susceptibility to CBO across all assay methods 411 
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(Figure 2). Edwards-Jones et al. conducted a study that observed similar results: known 412 
methicillin-resistant staphylococcus aureus (MRSA) strains exhibited susceptibility to a variety 413 
of EO, both together and individually, such as tea tree, geranium, and lavender. Both direct (DD) 414 
and non-direct methods of contact (VP) were utilized in the Edward-Jones et al. study, and the 415 
results concluded that the VP assay was significantly more effective, creating larger zones of 416 
inhibition for reasons similar to Goñi et al. (Edwards-Jones et al., 2004).  417 
 418 
As noted by the standard error bars displayed in Figures 2, 3, and 4, and standard deviation 419 
values of Table 2, there was some variation noted among CBO MIC values between replicates in 420 
the AD and BM assays. Zones of inhibition for the same isolate also varied between replicates in 421 
DD and VP methods. These variations can be attributed to a variety of factors. Past studies have 422 
shown that solvents and emulsifiers, such as DMSO and Tween-80, have the potential to 423 
decrease the antimicrobial properties of EO. However, this is not likely as the case for CBO 424 
where consistent, identical growth was identified for both the controls in the AD and BM trials. 425 
Each assay’s controls involved either plates or well treatments (rows in the 96-well plate) that 426 
contained MH broth with and without Tween-80 (Sanla‐Ead et al., 2012). Other factors could be 427 
attributed to the assay environment created, chemical properties of EO, or technique flaws in the 428 
procedure. One significant factor that differed between assay that could have been responsible 429 
for differing CBO MIC across assays was the number of cells used for each one. The BM 430 
method had 0.5 μL of the respective CBO solution in each well which contained approximately 431 
100,000 CFU of S. aureus, while the AD method had about 1,000,000 CFU transferred onto each 432 
predesignated spot on a CBO-infused MH plate. The VP and DD methods each had a lawn of 433 
100 μL of each 0.5 McF solution of an isolate, which contained about 10,000,000 CFU on each 434 
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plate with specific volumes of CBO solutions impregnated into each filter paper disc. Moreover, 435 
as the 0.5 McF standard is a qualitatively-based turbidity standard, it is possible that there were 436 
erroneously high or low numbers of CFU. Some colonies of S. aureus were more strongly 437 
pigmented than others among isolates, which could have created an erroneously low 0.5 McF for 438 
that standard. At the cellular level, it is still unknown how the ratio of EO concentration to the 439 
number of cells plays a role in EO MIC determination for bacteria such as S. aureus (Bakkali et 440 
al., 2008). Therefore, it is possible that the lower CFU counts for AD plates and BM wells were 441 
more susceptible to lower CBO concentrations, resulting in lower CBO MIC values in 442 
comparison to the VP and DD methods that had higher S. aureus CFU counts. A more accurate, 443 
reliable way of creating solutions that contain 1x108 CFU/mL should be utilized in future 444 
experiments to avoid significant variations in the number of cells used in each assay. 445 
 446 
Another reason could be that AD methodology is usually utilized as a preliminary screening 447 
for the existence antimicrobial activity of a material. Once the presence of antimicrobial activity 448 
is confirmed, more detailed assays to determine the actual antimicrobial MIC for a microbe 449 
follow, suggesting that AD assays should not be used to determine CBO MIC values (Burt, 450 
2004). This could explain the considerable number of outliers that were recorded for the DD trial 451 
as displayed in Figure 6. However, there was no standard deviation of the CBO MIC values 452 
because of the way the CBO MIC were calculated: the lowest concentration of CBO to create a 453 
significant zone of clear inhibition was noted as the CBO MIC value, and isolate treatments were 454 
repeated until both replicates in duplicate produced zones of inhibition at the same CBO 455 
concentration.  456 
 457 
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As seen in Table 1, Table 2, and Figure 2, the results for the VP assay contained the highest 458 
average CBO MIC values in comparison to all the other assays. As previously noted, the CBO 459 
concentrations for this assay had to be significantly increased to percentages as high as 80 460 
μgCBO/mL and the administered aliquot of solution had to be doubled from the recommended 461 
10 μL volume the VP assay methods were based upon (López et al., 2005). To emulate the 462 
worst-case conditions, therefore capture the higher end of the CBO MIC values, the VP plates 463 
remained uncovered when they were transferred into the incubator. Covering and sealing the 464 
plates could have produced more accurate and or lower CBO MIC values by preventing the 465 
aromatic compounds responsible for the EO’s antimicrobial properties from escaping. VP’s CBO 466 
MIC values for each isolate were the only ones to significantly differ from all other assay 467 
methods and penicillin control susceptibility testing (p < 0.0001), but as seen in Figure 2, some 468 
isolates had CBO MIC values by VP that were several times greater than their CBO MIC values 469 
recorded for the other assays. Whether these significant differences of the CBO MIC values of 470 
the VP assay should be viewed as errors is challenged by a study conducted by Goñi et al. that 471 
compared the antimicrobial activity of clove and cinnamon EO against Gram positive and 472 
negative bacteria in VP and DD assays. They found that the VP phase created significantly 473 
“higher activity” and larger zones of inhibition than the DD assay  (Goñi et al., 2009). The 474 
differences observed between the assays’ EO MIC values was attributed to the physiochemical 475 
properties of the EO and their culture media interactions. The antimicrobial properties are largely 476 
attributed to the volatile compounds of EO, which are accounted for in VP assays. However, 477 
direct contact methods such as BM, DD, or AD allow the volatile components of the EO to 478 
escape, relying on the less volatile, hydrophilic compounds to diffuse through the agar and create 479 
the zone of inhibition without the primary, antimicrobial components that had volatilized into the 480 
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air. Because EO are hydrophobic and apolar in nature, they do not sufficiently diffuse through 481 
the agar media. So, the VP captures enough of the volatile components of the EO to create an 482 
equilibrium in the headspace of the plate of both hydrophobic and the hydrophilic components 483 
that can diffuse through the agar, thus the original hypothesis was not supported.  Moreover, as 484 
the antimicrobial properties of EO are very dependent on the method of administration and 485 
conditions, the solvents and solutions of the assays, significantly influence the solubility of the 486 
EO throughout the media, also altering EO MIC values for direct contact methods. Thus, this 487 
author boldly claimed that all direct-contact methods are unsuitable measures of evaluating the 488 
antimicrobial properties of EO (Goñi et al., 2009). Others have also claimed that the use of VP 489 
methods have been more effective in EO MIC determination than direct contact methods (López 490 
et al., 2005). However, several other studies have argued the validity of direct contact methods, 491 
such as DD and BM as well (Edwards-Jones et al., 2004; López et al., 2005, 2007; Zhang et al., 492 
2016). For this experiment, though, it is possible that the actual CBO MIC values for this assay 493 
are much lower than the values reported. As mentioned earlier, 128 observations for the VP 494 
assay in this experiment were not used for statistical analysis because no zones of inhibition were 495 
observed at 2 μg/mL, 1 μg/mL, 0.5 μg/mL, 0.25 μg/mL, 0.125 μg/mL, and the CBO 496 
concentrations were increased to 80 μgCBO/mL CBO, 40 μgCBO/mL CBO, 20 μgCBO/mL 497 
CBO, 10 μgCBO/mL CBO, 5 μgCBO/mL CBO, and 2.5 μgCBO/mL CBO. Future studies 498 
should explore CBO concentrations that fall within this range to find more accurate CBO MIC 499 
values for S. aureus.   500 
 501 
Linear regression models normally utilized to determine MIC breakpoints based on zone 502 
inhibition diameters were not utilized in this experiment (Brueggemann et al., 2001). However, 503 
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CLSI guidelines warn that these extrapolated MIC values from linear regression models don’t 504 
necessarily correspond to zone diameters as differences in assay methods, conditions, and the 505 
accuracy of measurements in databases differ (CLSI, 2013). We utilized a novel way of 506 
interpreting the correlation between zones of inhibition and CBO concentrations to determine 507 
MIC values. As it is acceptable for MIC values to range within a log2 dilution of each other, for 508 
zones of diameter to differ between isolates, and that CBO MIC values are determined from the 509 
lowest concentration to inhibit growth, Figures 6 and 7 were constructed. These Box and 510 
Whisker plots provide a visual representation of the zone of inhibition ranges associated with 511 
each CBO concentration, showing a correlation between the 2 variables. 512 
 513 
With current literature and this study’s results, it is imperative to determine which assay, or 514 
what aspects of an assay, most successfully evaluate the antimicrobial properties of EO. We 515 
speculate that the BM assay conditions were the most conducive to CBO properties overall. The 516 
individual wells contained significantly less solvent volume for the EO to have to diffuse 517 
through, included Tween-80 in all CBO solutions to ensure thorough mixing of the EO in the 518 
solution, and had the potential to create an equilibrium in the headspace of the EO hydrophobic 519 
and hydrophilic components because each plate was covered in Parafilm before they were placed 520 
into the incubator. Moreover, the use of the multichannel pipette and small amounts of solutions 521 
required to run this assay makes it easily replicable and cost-efficient. The other assays had to be 522 
run in duplicate to save both time and costs, as each isolate could require up to 12 MH plates to 523 
test a single CBO concentration. As predicted in our hypothesis, this assay produced the lowest 524 
CBO MIC values across assays. To confirm the validity of these findings, more trials of each 525 
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assay should be conducted as logistical reasons such as timing and costs limited the number of 526 
replicates of each procedure.  527 
 528 
 EO resistance has yet to be discovered. Further research will need to be conducted to 529 
determine if there is a relationship between penicillin susceptibility and EO susceptibility. 530 
Significant differences in direct and non-direct contact assays’ EO MIC values have been noted, 531 
and many researchers have altered current antimicrobial susceptibility for conventional 532 
antimicrobial agents to better suit the nature of EO such as time kill assays, agar wells, and 533 
visual indicators such as resazurin. The antimicrobial properties of EO are significantly affected 534 
by experimental conditions (Goñi et al., 2009; Balouiri et al., 2016). Therefore, it is imperative 535 
that the creation of EO conducive assays, not just “altered” conventional antimicrobial 536 
susceptibility tests are developed so EO can be successfully utilized in the pharmaceutical field.  537 
 538 
 539 
CONCLUSION 540 
 The 48 S. aureus isolates collected from organic dairy farms across Vermont exhibited 541 
significant susceptibility to CBO. It was noted that the direct and non-direct methods of 542 
susceptibility testing produced significant differences in CBO MIC values, and further research 543 
should be done to analyze the effect of strain by assay type. However, the BM assay created an 544 
environment that was the most conducive to the volatile nature of EO, compared to the other 3 545 
assays. Our results also suggested that the diameter of the zone of inhibition increased with CBO 546 
concentration. Additionally, 7 S. aureus isolates normally resistant to penicillin exhibited 547 
consistent susceptibility to CBO in all 4 assays. Our results emphasize the need of more 548 
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standardized methods and innovative susceptibility tests tailored to the nature of EO to be 549 
utilized and created. Such antimicrobial susceptibility tests would provide a solid foundation for 550 
the potential of EO serving as alternative antimicrobial agent treatments for humans and animals 551 
alike.  552 
 553 
 554 
 555 
 556 
 557 
 558 
 559 
 560 
 561 
 562 
 563 
 564 
 565 
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 567 
 568 
 569 
 570 
 571 
25 
 
ACKNOWLEDGEMENTS 572 
I thank Dr. John Barlow, Ariela Burk, Theresa Astmann, Brooke Pietrefessa, Amber Davis, and 573 
Robert Mugabi, both current and former members of the Barlow Laboratory, as well as Corey 574 
Pettengill, for their help, guidance, and support throughout this research process. I also thank Dr. 575 
Todd Pritchard and Dr. Julie Smith for reviewing my paper, as well as the rest of the DUR 576 
Committee that granted me this opportunity.  577 
 578 
 579 
 580 
 581 
 582 
 583 
 584 
 585 
 586 
 587 
 588 
 589 
 590 
 591 
\ 592 
 593 
 594 
26 
 
REFERENCES 595 
Ali, S.M., A.A. Khan, I. Ahmed, M. Musaddiq, K.S. Ahmed, H. Polasa, L.V. Rao, C.M. 596 
Habibullah, L.A. Sechi, and N. Ahmed. 2005. Antimicrobial activities of Eugenol and 597 
Cinnamaldehyde against the human gastric pathogen Helicobacter pylori. Ann. Clin. 598 
Microbiol. Antimicrob. 4:20. doi:10.1186/1476-0711-4-20. 599 
Bakkali, F., S. Averbeck, D. Averbeck, and M. Idaomar. 2008. Biological effects of essential oils 600 
– A review. Food Chem. Toxicol. 46:446–475. doi:10.1016/j.fct.2007.09.106. 601 
Balouiri, M., M. Sadiki, and S.K. Ibnsouda. 2016. Methods for in vitro evaluating antimicrobial 602 
activity: A review. J. Pharm. Anal. 6:71–79. doi:10.1016/j.jpha.2015.11.005. 603 
Becerril, R., R. Gómez-Lus, P. Goñi, P. López, and C. Nerín. 2007. Combination of analytical 604 
and microbiological techniques to study the antimicrobial activity of a new active food 605 
packaging containing cinnamon or oregano against E. coli and S. aureus. Anal. Bioanal. 606 
Chem. 388:1003–1011. doi:10.1007/s00216-007-1332-x. 607 
Brueggemann, A.B., M.A. Pfaller, and G.V. Doern. 2001. Use of Penicillin MICs To Predict In 608 
Vitro Activity of Other β-Lactam Antimicrobial Agents againstStreptococcus 609 
pneumoniae. J. Clin. Microbiol. 39:367–369. doi:10.1128/JCM.39.1.367-369.2001. 610 
Burt, S. 2004. Essential oils: their antibacterial properties and potential applications in foods—a 611 
review. Int. J. Food Microbiol. 94:223–253. doi:10.1016/j.ijfoodmicro.2004.03.022. 612 
Caccioni, D.R.L., M. Guizzardi, D.M. Biondi, Agatino Renda, and G. Ruberto. 1998. 613 
Relationship between volatile components of citrus fruit essential oils and antimicrobial 614 
27 
 
action on Penicillium digitatum and Penicillium italicum. Int. J. Food Microbiol. 43:73–615 
79. doi:10.1016/S0168-1605(98)00099-3. 616 
Cardoso-Ugarte, G.A., A. López-Malo, and M.E. Sosa-Morales. 2016. Chapter 38 - Cinnamon 617 
(Cinnamomum zeylanicum) Essential Oils. V.R. Preedy, ed. Academic Press, San Diego. 618 
CLSI. 2013. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for 619 
Bacteria Isolated from Animals: Approved Standard. Fourth. Clinical and Laboratory 620 
Standards Institute, Wayne, PA. 621 
De Kruijf, N., M. Van Beest, R. Rijk, T. Sipiläinen-Malm, P. Paseiro Losada, and B. De 622 
Meulenaer. 2002. Active and intelligent packaging: applications and regulatory aspects. 623 
Food Addit. Contam. 19:144–162. doi:10.1080/02652030110072722. 624 
Edwards-Jones, V., R. Buck, S.G. Shawcross, M.M. Dawson, and K. Dunn. 2004. The effect of 625 
essential oils on methicillin-resistant Staphylococcus aureus using a dressing model. 626 
Burns 30:772–777. doi:10.1016/j.burns.2004.06.006. 627 
Friedman, M. 2017. Chemistry, Antimicrobial Mechanisms, and Antibiotic Activities of 628 
Cinnamaldehyde against Pathogenic Bacteria in Animal Feeds and Human Foods. J. 629 
Agric. Food Chem. 65:10406–10423. doi:10.1021/acs.jafc.7b04344. 630 
Goñi, P., P. López, C. Sánchez, R. Gómez-Lus, R. Becerril, and C. Nerín. 2009. Antimicrobial 631 
activity in the vapour phase of a combination of cinnamon and clove essential oils. Food 632 
Chem. 116:982–989. doi:10.1016/j.foodchem.2009.03.058. 633 
28 
 
Hammer, K.A., C.F. Carson, and T.V. Riley. 1999. Antimicrobial activity of essential oils and 634 
other plant extracts. J. Appl. Microbiol. 86:985–990. doi:10.1046/j.1365-635 
2672.1999.00780.x. 636 
Hili, P., C.S. Evans, and R.G. Veness. 1997. Antimicrobial action of essential oils : the effect of 637 
dimethylsulphoxide on the activity of cinnamon oil. Lett. Appl. Microbiol. 24:269–275. 638 
doi:10.1046/j.1472-765X.1997.00073.x. 639 
Janssen, A.M., J.J.C. Scheffer, and A.B. Svendsen. 1987. Antimicrobial Activity of Essential 640 
Oils: A 1976-1986 Literature Review. Aspects of the Test Methods. Planta Med. 53:395–641 
398. doi:10.1055/s-2006-962755. 642 
Kurt Bauer, Dorothea Garbe, and Horst Surburg. 2001. Common Fragance and Flavor Materials. 643 
Preparation, Properties, and Uses. Wiley-VCH Verl. GmbH Co 213. 644 
doi:10.1002/3527600205. 645 
Li, Y., D. Kong, and H. Wu. 2013. Analysis and evaluation of essential oil components of 646 
cinnamon barks using GC–MS and FTIR spectroscopy. Ind. Crops Prod. 41:269–278. 647 
doi:10.1016/j.indcrop.2012.04.056. 648 
López, P., C. Sánchez, R. Batlle, and C. Nerín. 2005. Solid- and Vapor-Phase Antimicrobial 649 
Activities of Six Essential Oils:  Susceptibility of Selected Foodborne Bacterial and 650 
Fungal Strains. J. Agric. Food Chem. 53:6939–6946. doi:10.1021/jf050709v. 651 
López, P., C. Sanchez, R. Batlle, and C. Nerín. 2007. Vapor-phase activities of cinnamon, thyme, 652 
and oregano essential oils and key constituents against foodborne microorganisms. J. 653 
Agric. Food Chem. 55:4348–4356. doi:10.1021/jf063295u. 654 
29 
 
Lv, F., H. Liang, Q. Yuan, and C. Li. 2011. In vitro antimicrobial effects and mechanism of 655 
action of selected plant essential oil combinations against four food-related 656 
microorganisms. Food Res. Int. 44:3057–3064. doi:10.1016/j.foodres.2011.07.030. 657 
Matusiak, K., W. Machnowski, H. Wrzosek, J. Polak, K. Rajkowska, K. Śmigielski, A. Kunicka-658 
Styczyńska, and B. Gutarowska. 2018. Application of Cinnamomum zeylanicum 659 
essential oil in vapour phase for heritage textiles disinfection. Int. Biodeterior. Biodegrad. 660 
131:88–96. doi:10.1016/j.ibiod.2017.02.011. 661 
Mullen, K.A.E., K.L. Anderson, and S.P. Washburn. 2014. Effect of 2 herbal intramammary 662 
products on milk quantity and quality compared with conventional and no dry cow 663 
therapy. J. Dairy Sci. 97:3509–3522. doi:10.3168/jds.2013-7460. 664 
Oussalah, M., S. Caillet, L. Saucier, and M. Lacroix. 2006. Antimicrobial effects of selected 665 
plant essential oils on the growth of a Pseudomonas putida strain isolated from meat. 666 
Meat Sci. 73:236–244. doi:10.1016/j.meatsci.2005.11.019. 667 
Pyörälä, S. 2009. Treatment of mastitis during lactation. Ir. Vet. J. 62:S40–S44. 668 
doi:10.1186/2046-0481-62-S4-S40. 669 
Sanla‐Ead, N., A. Jangchud, V. Chonhenchob, and P. Suppakul. 2012. Antimicrobial Activity of 670 
Cinnamaldehyde and Eugenol and Their Activity after Incorporation into Cellulose-based 671 
Packaging Films. Packag. Technol. Sci. 25:7–17. doi:10.1002/pts.952. 672 
Suppakul, P. 2016. Chapter 39 - Cinnamaldehyde and Eugenol: Use in Antimicrobial Packaging. 673 
J. Barros-Velázquez, ed. Academic Press, San Diego. 674 
30 
 
Vieira-Brock, P.L., B.M. Vaughan, and D.L. Vollmer. 2017. Comparison of antimicrobial 675 
activities of natural essential oils and synthetic fragrances against selected environmental 676 
pathogens. Biochim. Open 5:8–13. doi:10.1016/j.biopen.2017.09.001. 677 
World Health Organization. 2017. Antibacterial agents in clinical development: an analysis of 678 
the antibacterial clinical development pipeline, including tuberculosis. 679 
Zhang, Y., Pingping Jiang, SiewYoung Quek, Xiaoyu Liu, and Yifei Wang. 2016. Antibacterial 680 
activity and mechanism of cinnamon essential oil against Escherichia coli and 681 
Staphylococcus aureus. Food Control 59:282–289. doi:10.1016/j.foodcont.2015.05.032. 682 
Zwald, A.G., P.L. Ruegg, J.B. Kaneene, L.D. Warnick, S.J. Wells, C. Fossler, and L.W. Halbert. 683 
2004. Management Practices and Reported Antimicrobial Usage on Conventional and 684 
Organic Dairy Farms1. J. Dairy Sci. 87:191–201. doi:10.3168/jds.S0022-0302(04)73158-685 
6. 686 
 687 
 688 
 689 
 690 
 691 
 692 
 693 
 694 
 695 
 696 
31 
 
Table 1. Table of Tukey’s multiple comparisons test directly compared the mean CBO MIC values 697 
recorded for each of the 48 isolates in the 4 assays and the known penicillin MIC values. All CBO MIC 698 
values differed from each other significantly (p < 0.001) by CBO treatment, but when compared to the 699 
average penicillin MIC values AD and BM assays’ CBO MIC values did not differ significantly 700 
(p=0.9282) and (p=0.9999), respectively. The following four assays were included in this test: broth 701 
microdilution (BM), agar disc diffusion (DD), vapor phase diffusion (VP), and agar dilution (AD). 702 
 703 
 704 
 705 
 706 
 707 
 708 
 709 
 710 
 711 
 712 
 713 
 714 
 715 
 716 
 717 
Tukey's multiple comparisons test Mean Diff. 95.00% CI of diff. Significant? Adjusted P Value
BM vs. DD -0.6309 -0.8583 to -0.4035 Yes <0.0001
BM vs. VP -27.99 -32.21 to -23.76 Yes <0.0001
BM vs. AD 0.199 0.1135 to 0.2844 Yes <0.0001
BM vs. Penicllin 0.1517 -0.3836 to 0.6869 No 0.9282
DD vs. VP -27.35 -31.51 to -23.2 Yes <0.0001
DD vs. AD 0.8299 0.6213 to 1.038 Yes <0.0001
DD vs. Penicllin 0.7826 0.2026 to 1.363 Yes 0.0034
VP vs. AD 28.18 23.98 to 32.39 Yes <0.0001
VP vs. Penicllin 28.14 23.98 to 32.29 Yes <0.0001
AD vs. Penicllin -0.04733 -0.571 to 0.4764 No 0.999
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Table 2. Table of the mean, range, and standard of the CBO MIC values for all 48 isolates among the 4 718 
antimicrobial susceptibility assays in comparison to the PEN MIC calculations. Each assay type is 719 
represented in each column: broth microdilution (BM), agar disc diffusion (DD), vapor phase diffusion 720 
(VP), and agar dilution (AD). 721 
 722 
 723 
 724 
 725 
 726 
 727 
 728 
 729 
 730 
 731 
 732 
 733 
 734 
 735 
 736 
 737 
Assay Type BM DD VP AD Penicllin
Minimum 0.1768 0.25 10 0.125 0.0625
25% Percentile 0.4591 1 20 0.25 0.0625
Median 0.5 1 20 0.3536 0.0625
75% Percentile 0.7071 2 40 0.3536 0.0625
Maximum 1 2 40 1 8
Mean 0.5566 1.188 28.54 0.3576 0.4049
Std. Deviation 0.183 0.5397 10.31 0.1652 1.277
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 738 
 739 
 740 
 741 
 742 
Figure 1a-b. Chemical structures of the 2 most abundant components found in CBO: trans-743 
cinnamaldehyde an aldehyde (a) and eugenol a phenol (b). Both are lightweight, aromatic compounds 744 
that are mainly responsible for CBO’s antimicrobial properties (Burt, 2004).  745 
 746 
 747 
 748 
 749 
 750 
 751 
 752 
 753 
 754 
 755 
 756 
 757 
 758 
 759 
 760 
 761 
 762 
 763 
 764 
 765 
 766 
 767 
a). b). 
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Figure 2.  Comparative bar graph depicting of all averaged CBO MIC values determined for each of the 768 
48 isolates tested in the 4 antimicrobial assays. Error bars (standard deviation) are included for AD and 769 
BM, no error bars shown for other 2 assays because there was complete agreement of the MIC between 770 
replicates within each isolate. The y-axis is set to a log 10 scale.    771 
 772 
 773 
 774 
 775 
 776 
 777 
 778 
 779 
 780 
 781 
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Figure 3. A bar graph of the average CBO MIC values calculated in the AD assay in comparison to their 782 
respective PEN MIC, measured in μg/mL and the CBO MIC were calculated as μgCBO/mL of 783 
solution. The y-axes are set to linear scales. 784 
 785 
 786 
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 Figure 4. A bar graph of the average CBO MIC values calculated in the BM assay in comparison to their 799 
respective PEN MIC, measured in μg/mL and the CBO MIC were calculated as μgCBO/mL of solution. 800 
Both y-axes are set to linear scales. 801 
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Figure 5. A Tukey Box and Whiskers plot provides a physical representation of the zones of inhibition 814 
range created by isolates in the VP assay. On average, the greater the CBO concentration used, the larger 815 
the zone of inhibition created for that isolate. The control treatment lacked CBO and contained only ethyl 816 
ether.  817 
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 Figure 6. A Tukey Box and Whiskers plot provides a physical representation of the zones of inhibition 831 
range created by isolates in the DD assay. On average, the greater the CBO concentration used, the larger 832 
the zone of inhibition created for that isolate. Significant outliers were recorded for the diameters of 833 
inhibition produced from the PEN control plates, indicated by the points that fall outside of the range of 834 
the whiskers. Previously conducted work in the Barlow Laboratory determined 28 mm to be a breakpoint 835 
within the data collected for zones of inhibition. H2O was used as the negative control for this assay.  836 
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Figure 7a-c. Images of Isolates 7-12 results for the first trial of the AD assay in Figure b of the 0.125 850 
μgCBO/mL CBO plate and Figure c of the 0.5 μgCBO/mL CBO plate compared to the control plate 851 
depicted in Figure a displaying pure, positive growth of all isolates. The red arrow in Figure b indicates 852 
the lack of growth for Isolate 10 at the 0.125 μgCBO/mL CBO, resulting in Isolate 10’s CBO MIC to be 853 
recorded as 0.125 μgCBO/mL. 854 
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Figure 8a-c. Images of MH plates used in the VP assay for Isolate 10. Figure a displays the placement of 881 
the paper disc impregnated with the 80 μgCBO/mL CBO solution on the center of the lid. Figure b 882 
exhibits positive, pure growth of Isolate 10 as a control plate compared to the zone of inhibition created 883 
with the treatment of 80 μgCBO/mL CBO indicated with the red arrow in Figure c.   884 
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 900 
Figure 9a-b. Images 96-well plates used for the BM CBO trials. A depicts a 96-well plate results being 901 
read through the reflection of a mirror. Rows represented CBO concentrations and columns included 902 
different S. aureus isolates. B presents the variety of results produced within a single 96-well plate. Small, 903 
white “pellets” of bacterial growth indicated positive growth. The lowest CBO concentration to display 904 
inhibited growth, a well without a “pellet” or growth present was recorded as the MIC. Colors of positive 905 
wells ranged from clear to a vibrant yellow as depicted on the right side of the 96-well plate in b.  906 
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Figure 10a-c. Images taken of MH plates used for the DD assay. Negative growth was indicated with a 922 
lack of zone of inhibited growth as indicated in a and b for isolate 6A. Positive growth was indicated by a 923 
clean zone of inhibition around the filter paper disc indicated in c for isolate 12A. Letters A – F 924 
represented different CBO concentrations, A representing the highest CBO concentration of  2 925 
μgCBO/mL CBO and F representing the lowest CBO concentration of 0.0625 μgCBO/mL CBO. Control 926 
plates containing both Penicillin and ddH2O were also tested.  927 
b). a). c). 
